argenx SE has grown revenue 112% a year over three years and 131% a year over five. Revenue growth, 3-year annual rate: +112% (Biotechnology median +17%). Revenue growth, 5-year rate: +131%, growth has slowed since the five-year average. Years of annual history on file: 11, FY2015 to FY2025, as filed.

ARGXargenx SE

Healthcare

$824.98+12% 1Y

$824.98

$663.9352 weeks$1.1K

Is it growing?

Excellent

Growing: revenue growing +89% year on year, earnings up +53% year on year, and operating margin widening (+89.5 points).

3 good

Revenue trend+89% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +131% a year.

Earnings trend+53% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+89.5 points operating

Trailing-twelve-month operating margin, 24.8% now against -64.7% a year earlier.

All from SEC EDGAR, as of Dec 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ARGX growing?

argenx SE has grown revenue 112% a year over three years and 131% a year over five.

+112%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal years as filed

Revenue growth, 5-year rate: +131%
Revenue growth, 5-year rate · +112% over three · growth has slowed since the five-year average
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed

Details›